Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

NCT: NCT02276547 · COMPLETED

NCT IDNCT02276547
StatusCOMPLETED
Start Date2015-02-05
Completion2024-12-09
SponsorShockwave Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑